Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
London
MedTech
IMU nabs $53M funding round to ‘decode’ the immune system
IMU Biosciences has landed a £40 million ($53 million) series A as it looks to move immune system analysis from analog to “high definition.”
Ben Adams
Jun 3, 2026 7:43am
Global uncertainties can't dampen upbeat Jefferies conference
Nov 24, 2025 3:00am
Jefferies London conference earns reputation as 'JPM for Europe'
Nov 18, 2025 10:00am
Medtronic to double its London center for AI, robotic surgery
Sep 23, 2025 2:30pm
Merck scraps £1B project, along with all R&D operations in UK
Sep 10, 2025 3:40pm
UK unveils £1B plan to become leading cancer research hub
May 2, 2025 9:25am
